Rigel Pharma (RIGL) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $1.08 +2.86%
EPS Growth %: +62.5%
Financial Fact:
Interest income: 110K
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: +62.5%
Financial Fact:
Interest income: 110K
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.11), $0.02 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $11.37 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
- Oilfield firm SLB's profit rises on international drilling demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
